GXLV.L vs. GNOG.L
GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) and GNOG.L (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds tracking the MSCI World/Health Care NR USD, from State Street and Global X respectively. Both are passively managed. Over the past 3 years, GXLV.L returned 3.78%/yr vs -1.86%/yr for GNOG.L. At a 0.20 correlation, their price movements are largely independent. GXLV.L charges 0.15%/yr vs 0.50%/yr for GNOG.L.
Performance
GXLV.L vs. GNOG.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GXLV.L achieves a -1.77% return, which is significantly lower than GNOG.L's 12.27% return.
GXLV.L
- 1D
- 2.97%
- 1M
- 5.54%
- YTD
- -1.77%
- 6M
- -1.34%
- 1Y
- 16.55%
- 3Y*
- 3.78%
- 5Y*
- —
- 10Y*
- —
GNOG.L
- 1D
- 5.70%
- 1M
- 11.97%
- YTD
- 12.27%
- 6M
- 8.67%
- 1Y
- 60.03%
- 3Y*
- -1.86%
- 5Y*
- —
- 10Y*
- —
GXLV.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | -1.77% | 6.82% | 3.59% | -3.78% | 7.82% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | 12.27% | 12.03% | -16.98% | -11.35% | -13.23% |
Correlation
The correlation between GXLV.L and GNOG.L is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Apr 6, 2022 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GXLV.L vs. GNOG.L — Risk / Return Rank
GXLV.L
GNOG.L
GXLV.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GXLV.L | GNOG.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.82 | ||
| Sortino ratioReturn per unit of downside risk | -0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.35 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.16 | 3.44 | -1.29 |
| Martin ratioReturn relative to average drawdown | 4.76 | 8.72 | -3.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GXLV.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.34 | 2.16 | -0.82 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | -0.36 | +0.67 |
Drawdowns
GXLV.L vs. GNOG.L - Drawdown Comparison
The maximum GXLV.L drawdown since its inception was -19.59%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for GXLV.L and GNOG.L.
Loading charts...
Drawdown Indicators
| GXLV.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.59% | -67.50% | +47.91% |
Max Drawdown (1Y)Largest decline over 1 year | -11.51% | -17.16% | +5.65% |
Max Drawdown (3Y)Largest decline over 3 years | -19.59% | -47.66% | +28.07% |
Current DrawdownCurrent decline from peak | -5.07% | -41.78% | +36.71% |
Average DrawdownAverage peak-to-trough decline | -6.15% | -44.20% | +38.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.07% | 6.79% | +2.28% |
Volatility
GXLV.L vs. GNOG.L - Volatility Comparison
The current volatility for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) is 5.53%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 7.97%. This indicates that GXLV.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GXLV.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 7.97% | -2.44% |
Volatility (6M)Calculated over the trailing 6-month period | 12.37% | 19.73% | -7.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.62% | 27.38% | -8.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.60% | 31.21% | -10.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.60% | 31.21% | -10.61% |
GXLV.L vs. GNOG.L - Expense Ratio Comparison
GXLV.L has a 0.15% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.
Dividends
GXLV.L vs. GNOG.L - Dividend Comparison
Neither GXLV.L nor GNOG.L has paid dividends to shareholders.
Frequently Asked Questions
GXLV.L and GNOG.L have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.50% for GNOG.L.
Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: State Street and Global X. Their fees differ too: 0.15% for GXLV.L and 0.50% for GNOG.L.
Find the right allocation for GXLV.L and GNOG.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer